[POSSIBILITIES AND ADVANTAGES OF FIBRINOLYTIC DRUGS IN THERAPY OF KIDNEY DISEASE IN PREGNANCY].
D001778:Blood Coagulation Disorders; D004358:Drug Therapy; D005260:Female; D005342:Fibrinolysis; D005343:Fibrinolytic Agents; D006801:Humans; D007674:Kidney Diseases; D009525:Niacin; D009539:Nicotinic Acids; D011225:Pre-Eclampsia; D011247:Pregnancy; D013806:Theophylline
D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D009525:Niacin; D013806:Theophylline
BLOOD COAGULATION DISORDERS; DRUG THERAPY; FIBRINOLYSIS; NICOTINIC ACID; PREGNANCY; PREGNANCY TOXEMIAS; THEOPHYLLINE
POSSIBILITA' E VANTAGGI DEI FARMACI FIBRINOLITICI NELLA TERAPIA DELLA NEFROPATIA GRAVIDICA.